INTEGRIS-IPF Enrollment Complete
Enrollment in the INTEGRIS-IPF trial is complete.
Pliant would like to thank our INTEGRIS-IPF clinical sites, investigators and study teams for their assistance in the successful execution of this study.
A special thanks to the clinical participants and their families and support networks for helping us advance this important program.
Based upon the positive data from the INTEGRIS-IPF reported to date, Pliant is planning a late-stage clinical trial.
Please check back for additional details on our late-stage trial.
For more information
To learn more about our trials, please visit clinicaltrials.gov or contact us at email@example.com.